Gaucher Disease; Enrollment Underway For Trial Of Investigational Oral Medication
Gaucher Disease; Enrollment Underway For Trial Of Investigational Oral Medication
About this item
Full title
Gaucher Disease; Enrollment Underway For Trial Of Investigational Oral Medication
Publisher
Atlanta: NewsRx
Journal title
Virus Weekly, 2001, p.9
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Type 1 Gaucher disease is the most common genetic disease affecting Jewish people of Eastern European (Ashkenazi Jewish) ancestry and is caused by an inherited enzyme deficiency that prevents the body from breaking down a lipid (or fat molecule) called glucocerebroside. This results in an enlargement of the liver and/or spleen, where the lipids acc...
Alternative Titles
Full title
Gaucher Disease; Enrollment Underway For Trial Of Investigational Oral Medication
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_212988905
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_212988905
Other Identifiers
ISSN
1531-6424
E-ISSN
1532-4710
How to access this item
Log in as a Library member
